---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009786"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2025-03-11T23:59:59+00:00"
generated_at: "2026-05-24T23:23:01.824470+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lixte terminates at-the-market equity facility with WallachBeth Capital; effective March 18, 2025

## Summary
- Notice of termination of Sales Agreement with WallachBeth Capital LLC given on March 7, 2025.
- Termination becomes effective ten days after notice, i.e., March 18, 2025.
- Company plans to explore alternatives to raise additional equity capital.

## SEC filing metadata
- accession: 0001493152-25-009786
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2025-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315225009786/0001493152-25-009786-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315225009786/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009786
- JSON: https://secwatch.observer/filing/0001493152-25-009786.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009786.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.